The Clinical Study of Personalized Therapy for Non-small Cell Lung Cancer Based on ERCC1/RRM1/TS/Beta-Tubulin Expression
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Carboplatin; Cisplatin; Docetaxel; Gemcitabine; Pemetrexed
- Indications Non-small cell lung cancer
- Focus Biomarker; Therapeutic Use
- Acronyms PTINCLC
- 17 Dec 2014 Biomarkers information updated
- 11 Feb 2013 New trial record